Researchers will develop innovative tools to study dilated cardiomyopathy, a common cause of heart failure, in Doberman pinschers, a high at-risk breed.
Researchers will conduct a clinical trial investigating the safety and anticancer effectiveness of trametinib, a drug to treat companion dogs with aggressive cancers.
Researchers will evaluate if a collar-mounted monitor is a valid tool for measuring activity in dogs. This is potentially useful for owners and veterinarians to help gauge ongoing pet health concerns.
December 5, 2019 – Morris Animal Foundation is a proud recipient of four 2019 MarCom awards, an international competition honoring excellence in marketing and communication.